These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36543441)

  • 1. Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention.
    Kovach CP; Hebbe A; Glorioso TJ; Barrett C; Barón AE; Mavromatis K; Valle JA; Waldo SW
    JACC Cardiovasc Interv; 2022 Dec; 15(24):2475-2486. PubMed ID: 36543441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.
    Valle JA; Glorioso TJ; Bricker R; Barón AE; Armstrong EJ; Bhatt DL; Rao SV; Plomondon ME; Serruys PW; Keppetein AP; Sabik JF; Dressler O; Stone GW; Waldo SW
    JAMA Cardiol; 2019 Aug; 4(8):727-735. PubMed ID: 31241721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.
    Lee JM; Hwang D; Choi KH; Lee HJ; Song YB; Cho YK; Nam CW; Hahn JY; Shin ES; Doh JH; Hoshino M; Hamaya R; Kanaji Y; Murai T; Zhang JJ; Ye F; Li X; Ge Z; Chen SL; Kakuta T; Koo BK
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009232. PubMed ID: 32895005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease.
    Choi KH; Lee JM; Koo BK; Nam CW; Shin ES; Doh JH; Rhee TM; Hwang D; Park J; Zhang J; Kim KJ; Hu X; Wang J; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Akasaka T
    JACC Cardiovasc Interv; 2018 Feb; 11(3):237-245. PubMed ID: 29361444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
    Alidoosti M; Saroukhani S; Lotfi-Tokaldany M; Jalali A; Sobh-Rakhshankhah A
    Cardiovasc Revasc Med; 2016; 17(5):308-12. PubMed ID: 27198530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.
    Armstrong EJ; Graham LA; Waldo SW; Valle JA; Maddox TM; Hawn MT
    JACC Cardiovasc Interv; 2017 Feb; 10(4):329-338. PubMed ID: 28161261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease.
    Lin S; Guan C; Wu F; Xie L; Zou T; Shi Y; Chen S; He L; Xu B; Zheng Z
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011312. PubMed ID: 35167333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.
    Farooq V; Serruys PW; Bourantas CV; Zhang Y; Muramatsu T; Feldman T; Holmes DR; Mack M; Morice MC; Ståhle E; Colombo A; de Vries T; Morel MA; Dawkins KD; Kappetein AP; Mohr FW
    Circulation; 2013 Jul; 128(2):141-51. PubMed ID: 23766350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.